BMS is a New York-based biopharmaceutical firm that develops and commercializes medicines for treating patients prevail over serious diseases.
Business Model:
Revenue: $47B
Employees: 10,001-999,999
Address: 430 E. 29th Street
City: New York
State: NY
Zip: 10016
Country: US
BMS is a New York-based biopharmaceutical firm that develops and commercializes medicines for treating patients prevail over serious diseases.
Contact Phone:
+18003322056
Contact Email:
Listed Exchange:
NYSE
IPO Date:
5/9/2013
IPO Valuation:
$246M
Ticker Symbol:
BMY
IPO Price:
$14/share
Amount Raised:
$325M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/1929 | IPO | - | 2/2012 | Venture Round | $10.8M | 5/2009 | Venture Round | $7.7M | 11/2009 | Series A | 4 | $25M |
Venrock Lilly Ventures Flagship Pioneering ARCH Venture Partners Venrock |
3/2012 | Venture Round | 6 | $30M |
Lilly Ventures OUP (Osage University Partners) OrbiMed Flagship Pioneering Venrock ARCH Venture Partners Lilly Ventures OUP (Osage University Partners) OrbiMed Flagship Pioneering |
3/2013 | Series B | 6 | $30M |
Flagship Pioneering ARCH Venture Partners Altitude Life Science Ventures Polaris Partners Lilly Ventures OUP (Osage University Partners) Flagship Pioneering ARCH Venture Partners Altitude Life Science Ventures Polaris Partners Lilly Ventures OUP (Osage University Partners) |
7/1929 | IPO | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|